Namibia vs East Timor: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Namibia
83.0%
in 2025
East Timor
82.0%
in 2025
Namibia rank
104th
East Timor rank
106th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Namibia
- East Timor
How they compare
Namibia currently reports 83.0% against 82.0% in East Timor, a difference of 1.0%.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was East Timor ahead.
Namibia ranks 104th and East Timor ranks 106th of 194 countries.
Namibia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Namibia | East Timor | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 35.0% | 0.0% | 35.0% | Namibia |
| 2020s | 80.7% | 36.5% | 44.2% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Namibia or East Timor?
- Namibia, at 83.0% against 82.0% in East Timor as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Namibia and East Timor?
- 1.0%, with Namibia ahead.
- How many years of comparable data are there for Namibia and East Timor?
- 18 years are reported by both, from 2008 to 2025.
- How do Namibia and East Timor rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Namibia ranks 104th and East Timor ranks 106th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.